| (Values in U.S. Thousands) | Nov, 2022 | Nov, 2021 | Nov, 2020 | Nov, 2019 | Nov, 2018 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | -480 | -1,089 | -1,238 | -3,412 | -3,245 |
| Net Income Growth | +55.89% | +12.04% | +63.72% | -5.16% | -95.81% |
Pascal Biosciences Inc (PAS.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Pascal Biosciences Inc is engaged in the research and development of products for the treatment of cancers, and improvement of the immune system. The company has one operating segment, biotechnology research and development with lab and computer equipment in the United States of America.